End-of-day quote
Johannesburg S.E.
06:00:00 2024-07-14 pm EDT
|
5-day change
|
1st Jan Change
|
107.4
ZAR
|
-0.54%
|
|
-0.79%
|
-2.07%
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
11,764
|
12,314
|
9,243
|
11,574
|
11,335
|
-
|
-
|
Enterprise Value (EV)
1 |
11,764
|
12,314
|
14,588
|
15,912
|
14,483
|
13,450
|
11,985
|
P/E ratio
|
-
|
10.1
x
|
9.98
x
|
9.86
x
|
7.43
x
|
5.81
x
|
4.82
x
|
Yield
|
5.33%
|
-
|
8.84%
|
2%
|
3.17%
|
5.47%
|
6.7%
|
Capitalization / Revenue
|
0.47
x
|
0.47
x
|
0.26
x
|
0.31
x
|
0.29
x
|
0.28
x
|
0.26
x
|
EV / Revenue
|
0.47
x
|
0.47
x
|
0.41
x
|
0.42
x
|
0.38
x
|
0.33
x
|
0.28
x
|
EV / EBITDA
|
3.54
x
|
-
|
4.09
x
|
4.32
x
|
3.62
x
|
3
x
|
2.39
x
|
EV / FCF
|
-
|
-
|
-6.53
x
|
10.2
x
|
9.87
x
|
7.34
x
|
4.99
x
|
FCF Yield
|
-
|
-
|
-15.3%
|
9.78%
|
10.1%
|
13.6%
|
20%
|
Price to Book
|
-
|
-
|
-
|
0.94
x
|
0.84
x
|
0.77
x
|
0.7
x
|
Nbr of stocks (in thousands)
|
109,944
|
109,944
|
105,518
|
105,518
|
105,518
|
-
|
-
|
Reference price
2 |
107.0
|
112.0
|
87.60
|
109.7
|
107.4
|
107.4
|
107.4
|
Announcement Date
|
2/25/20
|
3/2/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
24,799
|
26,053
|
35,583
|
37,500
|
38,446
|
40,546
|
42,953
|
EBITDA
1 |
3,326
|
-
|
3,570
|
3,683
|
4,005
|
4,485
|
5,023
|
EBIT
1 |
2,031
|
-
|
2,047
|
2,571
|
2,942
|
3,403
|
3,925
|
Operating Margin
|
8.19%
|
-
|
5.75%
|
6.86%
|
7.65%
|
8.39%
|
9.14%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
1,759
|
2,097
|
2,556
|
3,123
|
3,729
|
Net income
1 |
-
|
-
|
959
|
1,174
|
1,561
|
2,002
|
2,423
|
Net margin
|
-
|
-
|
2.7%
|
3.13%
|
4.06%
|
4.94%
|
5.64%
|
EPS
2 |
-
|
11.12
|
8.780
|
11.12
|
14.46
|
18.48
|
22.28
|
Free Cash Flow
1 |
-
|
-
|
-2,235
|
1,556
|
1,467
|
1,833
|
2,402
|
FCF margin
|
-
|
-
|
-6.28%
|
4.15%
|
3.82%
|
4.52%
|
5.59%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
42.25%
|
36.64%
|
40.87%
|
47.82%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
132.54%
|
94.02%
|
91.54%
|
99.1%
|
Dividend per Share
2 |
5.700
|
-
|
7.740
|
2.190
|
3.410
|
5.880
|
7.195
|
Announcement Date
|
2/25/20
|
3/2/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 S1
|
---|
Net sales
1 |
18,404
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
|
-
|
Net margin
|
-
|
EPS
2 |
5.960
|
Dividend per Share
|
-
|
Announcement Date
|
7/26/23
|
Fiscal Period: December |
2019
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
5,345
|
4,338
|
3,148
|
2,115
|
650
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
1.497
x
|
1.178
x
|
0.786
x
|
0.4716
x
|
0.1295
x
|
Free Cash Flow
1 |
-
|
-
|
-2,235
|
1,556
|
1,467
|
1,833
|
2,402
|
ROE (net income / shareholders' equity)
|
12.1%
|
-
|
-
|
9.83%
|
11.1%
|
12.5%
|
13.3%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
-
|
116.0
|
128.0
|
140.0
|
155.0
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
833
|
-
|
1,552
|
1,305
|
1,319
|
1,373
|
1,428
|
Capex / Sales
|
3.36%
|
-
|
4.36%
|
3.48%
|
3.43%
|
3.39%
|
3.32%
|
Announcement Date
|
2/25/20
|
3/2/22
|
2/28/23
|
2/27/24
|
-
|
-
|
-
|
Last Close Price
107.4
ZAR Average target price
124
ZAR Spread / Average Target +15.43% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.07% | 622M | | +21.93% | 69.07B | | -5.08% | 46.81B | | +22.39% | 44.24B | | +35.57% | 29.06B | | +5.43% | 18.51B | | +13.31% | 17.34B | | -8.06% | 15.6B | | -25.21% | 15.04B | | -30.74% | 11.91B |
Other Specialty Chemicals
|